Overview
Koninklijke Philips N.V., commonly known as Philips, is a multinational corporation headquartered in the Netherlands. It operates primarily in the healthcare industry, with a focus on diagnostic imaging, image-guided therapy, patient monitoring, and health informatics, as well as consumer health and home care products. Key projects of Philips in recent years have emphasized the integration of artificial intelligence in diagnostics and personalized healthcare solutions, showcasing its commitment to innovation in medical technology. The company's strategic initiatives are also geared toward sustainability, particularly in reducing its carbon footprint and promoting circular economy in its operations. Philips aims to improve people's health and well-being through meaningful innovation, aligning with global health trends and technological advancements.
Basic Stats
The share price of Koninklijke Philips N.V. - Depositary Receipt (Common Stock) as of 4 September 2025 is 23,40 € / share. This is a decrease of 0.00% from the prior week.
The Factor Analysis chart (below right) shows a view of Koninklijke Philips N.V. - Depositary Receipt (Common Stock) from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 950.57 MM |
| Earnings Date | |
| EPS (TTM) | 0.17 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | 0.53 |
| Short Shares Avail. | 10.00 MM |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | -12.69 % |
| Volatility (1 yr) | 0.36 |
| Beta | 0.58 |
| Sharpe Ratio (1 yr) | -0.47 |
| Sortino Ratio (1 yr) | -0.64 |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.01 |
| ROE | 0.01 |
| ROIC | 0.01 |
| CROIC | 0.00 |
| OCROIC | 0.06 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 72.26 /100 |
| Profitability | 44.40 /100 |
| Quality Score | 38.56 /100 |
| Value Score | |
| Momentum Score | 49.89 /100 |
| Stability (Low Vol) Score | 60.91 /100 |
| Analyst Sentiment | |
| Fund Sentiment | 57.17 /100 |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 8.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Koninklijke Philips N.V. - Depositary Receipt (Common Stock). An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2014-04-23 | RBC Capital | Outperform | Sector Perform | Downgrade |
| 2014-09-26 | Morgan Stanley | Equal-weight | Overweight | Upgrade |
| 2014-02-05 | ING | Buy | Hold | Downgrade |
| 2014-02-21 | Exane BNP Paribas | Neutral | Underperform | Downgrade |
| 2017-06-21 | Natixis | Buy | Neutral | Downgrade |
| 2016-12-12 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2013-01-23 | UBS | Neutral | Buy | Upgrade |
| 2014-04-23 | Espirito Santo | Buy | Neutral | Downgrade |
| 2016-08-10 | UBS | Neutral | Buy | Upgrade |
| 2016-03-21 | Deutsche Bank | Hold | Buy | Upgrade |
| 2016-02-16 | Jefferies | Hold | Underperform | Downgrade |
| 2015-07-28 | Societe Generale | Hold | Buy | Upgrade |
| 2017-10-16 | Exane BNP Paribas | Outperform | Neutral | Downgrade |
| 2013-07-23 | JP Morgan | Neutral | Overweight | Upgrade |
| 2013-10-28 | Kepler Cheuvreux | Buy | Hold | Downgrade |
| 2013-10-21 | WGZ Bank | Hold | Buy | Upgrade |
| 2020-01-13 | Bank of America | Buy | Maintains | |
| 2014-10-21 | UBS | Buy | Neutral | Downgrade |
| 2014-09-29 | ING | Hold | Buy | Upgrade |
| 2013-07-23 | LBBW Research | Sell | Hold | Upgrade |
| 2019-12-06 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2018-09-13 | Bernstein | Outperform | Initiate | |
| 2016-10-26 | HSBC | Hold | Buy | Upgrade |
| 2015-07-28 | Barclays | Underweight | Equal-Weight | Upgrade |
| 2015-01-27 | Petercam | Buy | Hold | Downgrade |
| 2013-06-06 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2013-02-19 | Societe Generale | Buy | Hold | Downgrade |
